Advertisement

Acta Neurochirurgica

, Volume 159, Issue 7, pp 1227–1236 | Cite as

Efficacy of endoscopic endonasal transsphenoidal surgery for Cushing’s disease in 230 patients with positive and negative MRI

  • Hélène CebulaEmail author
  • Bertrand Baussart
  • Chiara Villa
  • Guillaume Assié
  • Anne Boulin
  • Luc Foubert
  • Sorin Aldea
  • Saad Bennis
  • Michèle Bernier
  • François Proust
  • Stephan Gaillard
Original Article - Brain Tumors

Abstract

Object

The primary objective was to assess the remission rate, and the secondary objectives were to evaluate the early complications and recurrence rate and to define the predictive factors for the remission and recurrence rates.

Patients and methods

This prospective single-center study included 230 consecutive patients, operated on by a single surgeon for Cushing’s disease via a transsphenoidal endoscopic endonasal approach, over a 6-year period (2008–2013). The patients included in this series were all adults (>18 years of age), who presented with clinical and biological characteristics of Cushing’s disease confirmed based on dedicated MRI pituitary imaging. Biochemical remission was defined as a postoperative serum cortisol level <5 μg/dl on the 2nd day following surgery that required glucocorticoid replacement therapy.

Results

The remission rate for the global population (n = 230) with a follow-up of 21 ± 19.2 months concerned 182 patients (79.1%) divided into 132 patients (82.5%) with positive MRI and 50 patients (71.4%) with negative MRI with no statistically significant difference (p = 0.077). Complications occurred in 77 patients with no deaths. A total of 22% of patients had transient diabetes insipidus and 6.4% long-term diabetes insipidus, and no postoperatively CSF leakage was observed. The recurrence rate was 9.8% with a mean time of 32.7 ± 15.2 months. The predictive factors for the remission rate were the presence of pituitary microadenoma and a positive histology. No risk factors were involved regarding the recurrence rate.

Conclusion

Whatever the MRI results, the transsphenoidal endonasal endoscopic approach remains the gold standard treatment for Cushing’s disease. It was maximally effective with a remission rate of 79.1% and lower morbidity.

Keywords

Cushing’s disease Remission rate Transsphenoidal Endoscopic Adenoma Venous sampling 

Notes

Acknowledgements

The authors are grateful to Richard Medeiros, Medical Editor of Medical Editing International, for copy editing the manuscript and to Prof. Anheim Mathieu, Professor of Neurology, Dr. Chibbaro and Dr. Spatola for reviewing this article. We are also grateful for the various multidisciplinary discussions regarding these data during the EUROPIT Postgraduate course (2016, Annecy, France), which helped with the interpretation of our results. No funding was received for this research.

Compliance with ethical standards

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Human and animal rights and informed consent

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B (2005) Long-term remission rates after pituitary surgery for Cushing’s disease: the need for long-term surveillance. Clin Endocrinol 63:549–559. doi: 10.1111/j.1365-2265.2005.02380 CrossRefGoogle Scholar
  2. 2.
    Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 93:2454–2462CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Buchfelder M, Nistor R, Fahlbusch R, Huk WJ (1993) The accuracy of CT and MR evaluation of the sella turcica for detection of adrenocorticotropic hormone-secreting adenomas in Cushing disease. AJNR Am J Neuroradiol 14:1183–1190PubMedGoogle Scholar
  4. 4.
    Cannavo S, Almoto B, Dall’Asta C, Corsello S, Lovicu RM, De Menis E, Trimarchi F, Ambrosi B (2003) Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. Eur J Endocrinol/Eur Fed Endoc Soc 149:195–200CrossRefGoogle Scholar
  5. 5.
    Chandler WF, Barkan AL, Hollon T, Sakharova A, Sack J, Brahma B, Schteingart DE (2016) Outcome of transsphenoidal surgery for Cushing disease: a single-center experience over 32 years. Neurosurgery 78:216–223CrossRefPubMedGoogle Scholar
  6. 6.
    Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH (2003) Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 98:967–973CrossRefPubMedGoogle Scholar
  7. 7.
    Ciric I, Zhao JC, Du H, Findling JW, Molitch ME, Weiss RE, Refetoff S, Kerr WD, Meyer J (2012) Transsphenoidal surgery for Cushing disease: experience with 136 patients. Neurosurgery 70:70–80, discussion 80–71CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    De Tommasi C, Vance ML, Okonkwo DO, Diallo A, Laws ER Jr (2005) Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing’s disease or Nelson’s syndrome. J Neurosurg 103:825–830CrossRefPubMedGoogle Scholar
  9. 9.
    Dickerman RD, Oldfield EH (2002) Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg 97:1343–1349CrossRefPubMedGoogle Scholar
  10. 10.
    Friedman RB, Oldfield EH, Nieman LK, Chrousos GP, Doppman JL, Cutler GB Jr, Loriaux DL (1989) Repeat transsphenoidal surgery for Cushing’s disease. J Neurosurg 71:520–527CrossRefPubMedGoogle Scholar
  11. 11.
    Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB (2004) Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results. J Clin Endocrinol Metab 89:6348–6357CrossRefPubMedGoogle Scholar
  12. 12.
    Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Muller OA, Fahlbusch R (2008) Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg 108:9–18CrossRefPubMedGoogle Scholar
  13. 13.
    Jagannathan J, Sheehan JP, Jane JA Jr (2007) Evaluation and management of Cushing syndrome in cases of negative sellar magnetic resonance imaging. Neurosurg Focus 23, E3CrossRefPubMedGoogle Scholar
  14. 14.
    Jho HD, Carrau RL, Ko Y, Daly MA (1997) Endoscopic pituitary surgery: an early experience. Surg Neurol 47:213–222, discussion 222–213CrossRefPubMedGoogle Scholar
  15. 15.
    Lonser RR, Nieman L, Oldfield EH (2016) Cushing’s disease: pathobiology, diagnosis, and management. Journal of neurosurgery:1–14.  10.3171/2016.1.JNS152119
  16. 16.
    McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sheridan B, Atkinson AB (1993) Assessment of endocrine function after transsphenoidal surgery for Cushing’s disease. Clin Endocrinol 38:79–86CrossRefGoogle Scholar
  17. 17.
    Mehta GU, Lonser RR, Oldfield EH (2012) The history of pituitary surgery for Cushing disease. J Neurosurg 116:261–268CrossRefPubMedGoogle Scholar
  18. 18.
    Netea-Maier RT, van Lindert EJ, den Heijer M, van der Eerden A, Pieters GF, Sweep CG, Grotenhuis JA, Hermus AR (2006) Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing’s disease. Eur J Endocrinol/Eur Fed Endoc Soc 154:675–684CrossRefGoogle Scholar
  19. 19.
    Nieman LK (2015) Cushing’s syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol/Eur Fed Endoc Soc 173:M33–38CrossRefGoogle Scholar
  20. 20.
    Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A, Endocrine S (2015) Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100:2807–2831CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER Jr (2008) Outcomes after repeat transsphenoidal surgery for recurrent Cushing’s disease. Neurosurgery 63:266–270, discussion 270–261CrossRefPubMedGoogle Scholar
  22. 22.
    Pereira AM, van Aken MO, van Dulken H, Schutte PJ, Biermasz NR, Smit JW, Roelfsema F, Romijn JA (2003) Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing’s disease. J Clin Endocrinol Metab 88:5858–5864CrossRefPubMedGoogle Scholar
  23. 23.
    Prevedello DM, Pouratian N, Sherman J, Jane JA Jr, Vance ML, Lopes MB, Laws ER Jr (2008) Management of Cushing’s disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. J Neurosurg 109:751–759CrossRefPubMedGoogle Scholar
  24. 24.
    Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF (2002) Long-term follow-up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission. Clin Endocrinol 56:541–551CrossRefGoogle Scholar
  25. 25.
    Salenave S, Gatta B, Pecheur S, San-Galli F, Visot A, Lasjaunias P, Roger P, Berge J, Young J, Tabarin A, Chanson P (2004) Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas. J Clin Endocrinol Metab 89:3371–3376CrossRefPubMedGoogle Scholar
  26. 26.
    Semple PL, Laws ER Jr (1999) Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing’s disease. J Neurosurg 91:175–179CrossRefPubMedGoogle Scholar
  27. 27.
    Semple PL, Vance ML, Findling J, Laws ER Jr (2000) Transsphenoidal surgery for Cushing’s disease: outcome in patients with a normal magnetic resonance imaging scan. Neurosurgery 46:553–558, discussion 558–559CrossRefPubMedGoogle Scholar
  28. 28.
    Sheehan JM, Lopes MB, Sheehan JP, Ellegala D, Webb KM, Laws ER Jr (2000) Results of transsphenoidal surgery for Cushing’s disease in patients with no histologically confirmed tumor. Neurosurgery 47:33–36, discussion 37–39CrossRefPubMedGoogle Scholar
  29. 29.
    Shimon I, Ram Z, Cohen ZR, Hadani M (2002) Transsphenoidal surgery for Cushing’s disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 51:57–61, discussion 61–52CrossRefPubMedGoogle Scholar
  30. 30.
    Simmons NE, Alden TD, Thorner MO, Laws ER Jr (2001) Serum cortisol response to transsphenoidal surgery for Cushing disease. J Neurosurg 95:1–8CrossRefPubMedGoogle Scholar
  31. 31.
    Starke RM, Reames DL, Chen CJ, Laws ER, Jane JA Jr (2013) Endoscopic transsphenoidal surgery for Cushing disease: techniques, outcomes, and predictors of remission. Neurosurgery 72:240–247, discussion 247CrossRefPubMedGoogle Scholar
  32. 32.
    Swearingen B, Biller BM, Barker FG 2nd, Katznelson L, Grinspoon S, Klibanski A, Zervas NT (1999) Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 130:821–824CrossRefPubMedGoogle Scholar
  33. 33.
    Teramoto A, Yoshida Y, Sanno N, Nemoto S (1998) Cavernous sinus sampling in patients with adrenocorticotrophic hormone-dependent Cushing’s syndrome with emphasis on inter- and intracavernous adrenocorticotrophic hormone gradients. J Neurosurg 89:762–768. doi: 10.3171/jns.1998.89.5.0762 CrossRefPubMedGoogle Scholar
  34. 34.
    Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM (1993) Transsphenoidal resection in Cushing’s disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol 38:73–78CrossRefGoogle Scholar
  35. 35.
    Vallette-Kasic S, Dufour H, Mugnier M, Trouillas J, Valdes-Socin H, Caron P, Morange S, Girard N, Grisoli F, Jaquet P, Brue T (2000) Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy. Eur J Endocrinol/Eur Fed Endoc Soc 143:761–768CrossRefGoogle Scholar
  36. 36.
    Wagenmakers MA, Netea-Maier RT, van Lindert EJ, Timmers HJ, Grotenhuis JA, Hermus AR (2009) Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing’s disease (CD). Clin Endocrinol 70:274–280CrossRefGoogle Scholar
  37. 37.
    Wind JJ, Lonser RR, Nieman LK, DeVroom HL, Chang R, Oldfield EH (2013) The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing’s disease. J Clin Endocrinol Metab 98:2285–2293CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Wien 2017

Authors and Affiliations

  • Hélène Cebula
    • 1
    Email author
  • Bertrand Baussart
    • 2
  • Chiara Villa
    • 3
  • Guillaume Assié
    • 4
    • 5
    • 6
    • 7
    • 8
  • Anne Boulin
    • 9
  • Luc Foubert
    • 2
  • Sorin Aldea
    • 2
  • Saad Bennis
    • 2
  • Michèle Bernier
    • 3
  • François Proust
    • 1
  • Stephan Gaillard
    • 2
  1. 1.Department of NeurosurgeryHôpital HautepierreStrasbourgFrance
  2. 2.Department of NeurosurgeryHôpital FochSuresnesFrance
  3. 3.Department of PathologyHôpital FochSuresnesFrance
  4. 4.Institut National de la Santé et de la Recherche Médicale U1016Institut CochinParisFrance
  5. 5.Centre national de la recherche scientifique UMR8104ParisFrance
  6. 6.Sorbonne Paris CitéUniversité Paris DescartesParisFrance
  7. 7.Department of EndocrinologyCenter for Rare Adrenal Diseases Assistance Publique Hôpitaux de ParisParisFrance
  8. 8.Hôpital CochinParisFrance
  9. 9.Department of NeuroradiologyHôpital FochSuresnesFrance

Personalised recommendations